Clinical trials: Dysphoric Mood
HIV/AIDS, STI
Transgender Cohort Study of Gender Affirmation and HIV-related Health
This observational research study will evaluate medical gender affirmation delivered in primary care as an intervention to reduce disparities in HIV-related outcomes (e.g., low rates of PrEP uptake for HIV-uninfected patients…
- Conditions
- HIV/AIDS, STI, Gender Dysphoria, Transsexualism
- Trial name
- NCT03595956
- Testing
- Medical gender affirmation
- Where
- United States
- Volunteers
- 4,500 people, healthy volunteers welcome
- Sponsor
- Fenway Community Health
Gender Dysphoria Vaginoplasty Sexuality
Sexual Function of Trans Women After Vaginoplasty
Genital feminine affirming surgery may be an important step for transgender women. Vaginoplasty consists in the creation of external female genitalia and an operational vaginal cavity, and thus responds to major functional and…
- Trial name
- GGAS-SEX (NCT05292820)
- Testing
- Validated and non-validated questionnaire for exploration of sexuality and satisfaction after surgical procedure
- Where
- 3 sites in France
- Volunteers
- 158 people
- Sponsor
- Hospices Civils de Lyon
Transgender Health, Gender Dysphoria
Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women
Transgender women living with Human Immunodeficiency Virus (HIV) may prioritize gender-affirming hormonal therapy over antiretroviral drug therapy.
- Conditions
- Transgender Health, Gender Dysphoria, Transgender Women, Human Immunodeficiency Virus
- Trial name
- IDENTIFY (NCT04283656)
- Testing
- Doravirine/Lamivudine/Tenofovir, Spironolactone 100mg, Estradiol 2mg
- Where
- United States
- Volunteers
- 8 people, healthy volunteers welcome
- Sponsor
- Thomas Jefferson University
Gender Dysphoria, Transgender
Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy
The goal of this study is to learn about fertility preservation in the gender-diverse community. The main objectives it aims to understand are to: 1.
- Trial name
- NCT05863676
- Testing
- Oophorectomy, Infectious Disease Testing
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- University of Pittsburgh
Gender Dysphoria
Gender Dysphoria: Epidemiological Data
Retrospective study in a single academic regional transgender referral center. data from the cohort follow-up in CHRU de Nancy
- Trial name
- DyGenEpi (NCT04573127)
- Testing
- descriptive study
- Where
- France
- Volunteers
- 320 people
- Sponsor
- Central Hospital, Nancy, France
Gender Dysphoria
Metabolic Consequences of Cross-sex Hormonal Treatment
Retrospective study in a single academic regional transgender referral center. Analyse VAT, body composition and metabolic parameters in non-obese transgender subjects one year after starting gender-affirming hormone therapy and…
- Trial name
- DysGeMet (NCT04508231)
- Testing
- Gender-affirming hormone therapy
- Where
- France
- Volunteers
- 98 people
- Sponsor
- Central Hospital, Nancy, France
Gender Identity, Gender Dysphoria in Adolescents and Adults
Puberty, Testosterone, and Brain Development
Transmasculine youth (female sex assigned at birth, male gender identity) who begin clinical gender affirming hormone therapy (GAHT) with testosterone (T) may experience changes in headache.
- Conditions
- Gender Identity, Gender Dysphoria in Adolescents and Adults, Headache, Transgender
- Trial name
- NCT06670053
- Testing
- Testosterone
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- University of Colorado, Denver
Gender Dysphoria, Gender Identity Disorder
TransCare - Genital Surgery for Trans Women in Centralized vs. Decentralized Health Care Delivery Settings
Trans (i.e., transgender, transsexual) individuals experience a gender that does not match their sex assigned at birth (Gender Incongruence), which can lead to distress called gender dysphoria (formerly known as transsexualism).
- Conditions
- Gender Dysphoria, Gender Identity Disorder, Transsexualism, Gender Identity
- Trial name
- NCT03872648
- Where
- Germany
- Volunteers
- 64 people
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
Gender Dysphoria
Polyethylene-glycol Assisted Nerve Repair in Phalloplasty
Phalloplasty, a genitourinary surgery for transmasculine patients, reconstructs a neophallus using tissue transferred from other parts of the body to the groin.
- Trial name
- NCT05897086
- Testing
- Polyethylene Glycol 3350
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Vanderbilt University Medical Center
Sleep Disorder, Insulin Resistance
Sleep and IR in Transgender Adolescents
Disordered sleep is a health issue with significant impacts on physical and psychological well-being that has increased in prevalence, but its impact on transgender adolescents has not been fully quantified.
- Conditions
- Sleep Disorder, Insulin Resistance, Gender Dysphoria
- Trial name
- ATP (NCT05489159)
- Where
- United States
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Duke University
Gender Dysphoria
Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
The current project aims to improve the well-being of trans and nonbinary (TNB) individuals through an online intervention (Trans Care) targeting the reduction of symptoms of gender dysphoria.
- Trial name
- NCT05884307
- Testing
- Trans Care Web App
- Where
- United States
- Volunteers
- 138 people, healthy volunteers welcome
- Sponsor
- University of Wisconsin, Madison
Premenstrual Syndrome (PMS)
Treatment of Premenstrual Syndrome - Internet-based Self-help
The purpose of this study is to determine whether an internet-based CBT (iCBT) is effective in reducing the impairment caused by premenstrual symptoms.
- Trial name
- praemensis (NCT01961479)
- Testing
- Internet-based CBT for patients with PMS, Waiting list
- Where
- Germany
- Volunteers
- 174 people
- Sponsor
- Philipps University Marburg
Gender Dysphoria
Effects of Sex Steroids on the Serotonin System
The aim of this study is to prove the modulatory influence of sex hormones on serotonergic neurotransmission by determining the enzymatic processes involved in serotonin synthesis and degradation using positron emission…
- Trial name
- NCT02715232
- Testing
- Testosterone, Lynestrenol, Cyproterone Acetate
- Where
- Austria
- Volunteers
- 92 people, healthy volunteers welcome
- Sponsor
- Medical University of Vienna
Gender Dysphoria
The Strategic Use of Hyaluronic Acid Fillers and Neurotoxin to Influence Gender Perception in Transgender Individuals
Observational survey study of transgender individuals who have undergone cosmetic neurotoxin and soft tissue filler for the purpose of influencing gender perception.
- Trial name
- NCT04478214
- Where
- United States
- Volunteers
- 2 people, healthy volunteers welcome
- Sponsor
- Mountain Dermatology Specialists
Gender Identity, Gender Dysphoria, Adult
The Copenhagen Gender Identity Cohort
The goal of this observational study is to systematically collect data on adults seeking medical and surgical treatments for gender incongruence.
- Conditions
- Gender Identity, Gender Dysphoria, Adult, Gender Incongruence
- Trial name
- KIK (NCT06953908)
- Where
- Denmark
- Volunteers
- 2,000 people
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
Premenstrual Syndrome, Premenstrual Dysphoric Disorder
CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life
This study evaluates the feasibility and efficacy of the Samphire Guided Care (SGC) program a 12-week structured digital health program combining clinician-led onboarding, at-home neuromodulation using the Lutea tDCS device…
- Conditions
- Premenstrual Syndrome, Premenstrual Dysphoric Disorder, Dysmenorrhea, Endometriosis
- Trial name
- CREST (NCT07679074)
- Testing
- Lutea Transcranial Direct Current Stimulation (tDCS) Device, Samphire Guided Care Program
- Where
- United States
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Samphire Group, Inc.
Gender Dysphoria
Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content
Background: Sex hormones are believed to play an important role in the development and progression of cardiovascular disease. However, the gender gap in onset and mortality is not yet completely understood.
- Trial name
- NCT06245681
- Testing
- gender affirming hormone therapy
- Where
- Austria
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Medical University of Vienna
Gender Dysphoria, Voice Disorder Due to Transsexualism
Investigation of the Perceptual and Acoustic Voice in Trans Man
The aim of the study is to follow acoustic and perceptual voice changes in trans men during hormone therapy and to examine the relationship between psychosocial and vocal characteristics and testosterone measured in routine…
- Conditions
- Gender Dysphoria, Voice Disorder Due to Transsexualism, Transgender Persons, Hormone Replacement Therapy
- Trial name
- NCT05166083
- Testing
- Testosterone Hormon Therapy
- Where
- Turkey (Türkiye)
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- Hacettepe University
Depressive Disorder
Mild Depression 2 Week Observational Study
The purpose of this study is to assess whether the dysphoric-like depressive characteristics observed in people with epilepsy are unique to this patient population in comparison to three control groups: Mild Depression (enrolled…
- Trial name
- NCT00285831
- Where
- United States
- Volunteers
- 36 people
- Sponsor
- Stanford University
Premenstrual Dysphoric Disorder
Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)
The purpose of this study is to investigate the clinical efficacy of Levetiracetam in the treatment of symptoms of premenstrual dysphoric disorder (PMDD) in an open label study.
- Trial name
- pmdd (NCT00518570)
- Testing
- Levetiracetam
- Where
- United States
- Volunteers
- 7 people, healthy volunteers welcome
- Sponsor
- Berkshire Health Systems